Conversations in Bio: the future of the industry

Discussion about the future of the bio industry and the leadership qualities required for success.

Event Details

Location

swissnex San Francisco
730 Montgomery St., San Francisco, 94111 United States

Date

November 12, 2006 from 4:00 pm to 6:30 pm America/Los Angeles (UTC-07:00)

A kick off reception at swissnex features an intimate, exclusive conversation with Steven Burill, CEO of Burill and Company and Gregg H. Alton, Senior Vice President and General Counsel at Gilead Sciences, Inc.

Steve and Gregg will have a one-on-one discussion with the participants of the program to discuss the future of the bio industry and the leadership qualities required for success. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 35 years. An early pioneer, Mr. Burrill is one of the original architects of the industry and one of its most avid and sustained developers. In 2002, Mr. Burrill was recognized as the biotech investment visionary by the prestigious Scientific American magazine. He currently serves as Chairman of the Boards of Pharmasset, and Genomics and is a member of the Boards of Directors of Catalyst Biosciences, DepoMed, Targacept, and Third Wave Technologies.

Gregg Alton is responsible for legal affairs as well as Gilead’s government affairs activities. Mr. Alton is Chairman of the Board of BayBio, a San Francisco Bay Area life sciences industry organization, member of the board and treasurer of the Biotechnology Industry Organization’s General Counsel Committee, and a member of the advisory board of BIO Ventures for Global Health.

Program

5.00 pm doors open, registration and networking
5.30 pm welcome Steven Burrill, CEO, Burill & Company Gregg H. Alton, SVP and General Counsel of Gilead Sciences, Inc.
6.30 pm networking and finger food
7.30 pm doors close

Top